Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

2 hours ago 1
ARTICLE AD BOX
As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.
Read Entire Article
  1. Homepage
  2. category-label-
  3. Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

Related

DraftKings’ expensive bet on prediction markets is crushing its stock

DraftKings’ expensive bet on prediction markets is crushing ...

1 hour ago 0
What’s next for your portfolio after the decline in Big Tech stocks?

What’s next for your portfolio after the decline in Big Tech...

1 hour ago 0
Tesla’s Cybertruck is a masterclass in failing upwards

Tesla’s Cybertruck is a masterclass in failing upwards

1 hour ago 0
RIGHT SIDEBAR TOP AD

Trending

1. sebastian lelio
2. alcaraz
3. atp paris
4. sebastián lelio
5. lawsuit
6. oracle stock
7. antonio brown
8. orcl stock
9. burger king holiday countdown calendar
10. paige bueckers

Popular

Netflix investors are getting squeamish as Amazon makes inroads in the battle for streaming dominance

Netflix investors are getting squeamish as Amazon makes inro...

5 months ago 16
Some singles now expect their dates to pay for their Ubers while gas prices are so high

Some singles now expect their dates to pay for their Ubers w...

5 months ago 15
‘This is not a flash in the pan’ — why value stocks are beating growth by such a wide margin

‘This is not a flash in the pan’ — why value stocks are beat...

4 months ago 15
Here’s how SpaceX is pitching its IPO to everyday investors

Here’s how SpaceX is pitching its IPO to everyday investors

5 months ago 14
Jane Street Plans New Data Center as Compute Power Runs Scarce

Jane Street Plans New Data Center as Compute Power Runs Scar...

5 months ago 13
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexus Financial News 2026. All rights are reserved